Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
Age
18–44
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Delivered at the hospital system associated with the trial center
Delivered preterm singleton gestational age 24 weeks + 0 days to 34 weeks + 2 days
Willing to express milk at least 5 times every 24 hours during the observation period and 6 to 8 times every 24 hours during the treatment and post-treatment follow up
Produced \< 200 mL milk in 24 hours prior to randomization
Delivered 96 to 192 (+4) hours prior to randomization
You may not be if
Pre-pregnancy body mass index (BMI) \> 50 kg/m\^2
Mastitis
History of breast trauma, breast surgery, nipple piercing
Prolactin-releasing pituitary tumor, history of Sheehan's syndrome, pituitary surgery/radiation therapy
Pre-pregnancy insulin-dependent diabetes mellitus, polycystic ovarian syndrome. Note: gestational diabetes is allowed (also when requiring the use of insulin for treatment)
